Home Tools
Log in
Cart

Search Result

Search Results for " negative control "

20

Compounds

Cat No. Product Name Synonyms Targets
T38260 SP 600125, negative control JNK Inhibitor II, negative control
SP 600125, negative control is a methylated analog of SP 600125 and can be used as a negative control for SP 600125. SP 600125, negative control inhibits DTP3 and GADD45β/MKK7 (growth arrest and DNA damage-inducible β/me...
T39317 ELA-14 negative control
ELA-14 negative control is an inactive peptide that serves as a negative control for ELA-14.
T41227 ARCC 4 negative control
ARCC 4 negative control is a negative control for ARCC 4. Binds androgen receptors (AR) without inducing degradation.
TP2203 Bax inhibitor peptide, negative control Others
The compound is a negative control peptide for the Bax inhibitor peptides V5 and P5.
T71316 ERK Inhibitor II (Negative control)
ERK Inhibitor II (Negative control) effectively blocks extracellular signal-regulated kinase (ERK) and interferes with insulin receptor activation, serving as a useful tool in diabetes research.
T23150 PHGDH-inactive Others
inactive analog of the 3-phosphoglycerate dehydrogenase (PHGDH) inhibitors NCT-502 and NCT-503
T74869 SiRNA Negative Control
siRNA Negative Control, a 21-nucleotide siRNA, serves as a negative control.
T19578 TH-263 Others
TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
T24677 PS47 PS 47,PS-47 PDK
PS-47(PS 47) is an inactive E-isomer of PS48. PS48 is an activator of PDK1.
T71314 GL-V9
GL-V9 is an AMPK activator, protecting against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy.
T41214 (S)-BAY-293 BAY 294,BAY 293 Negative Control Ras
(S)-BAY-293 is a potent pan-KRAS inhibitor for the study of primary non-small lung and pancreatic cancers.
T10608 BRD5648 (R)-BRD0705 GSK-3
BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies.
T23176 PP 3 Src
PP 3 is a Negative control for the Src kinase inhibitor PP 2
T23237L RLLFT-NH2 acetate Others
RLLFT-NH2 acetate is a reversed amino acid sequence negative control peptide for TFLLR-NH2.
T23160 PIR 3.5 6,6′-Dithiodi(2-naphthol) PAK
PIR 3.5 (6,6′-Dithiodi(2-naphthol)) is a negative control of IPA 3 which is a Pak1 inhibitor.
T9554 SN-008 STING
SN-008 is a less active analog SN-011 which is a STING antagonist. SN-008 can be used as a negative control.
T35478 Cis VH 032, amine dihydrochloride (S,S,S)-AHPC
cis VH 032, amine dihydrochloride ((S,S,S)-AHPC) is a negative control for the functionalized VHL ligand VH 032, amine .
T22175L ZIP (SCRAMBLED) Acetate ZIP (SCRAMBLED) Acetate(908012-18-0 Free Base) Others
ZIP (SCRAMBLED) Acetate (ZIP (SCRAMBLED) Acetate (908012-18-0 Free Base)) is a scrambled peptide that can be used as a negative control for zeta inhibitory peptide (ZIP).
T7157 XY1 Histone Methyltransferase
XY1 is a very close analogue of SGC707 (a potent, selective, and non-competitive inhibitor of PRMT3 with IC50 of 31 nM), It is intended to be used as a negative control for SGC707 in studies involving PRMT3 action.
T2035 WHI-P258 EGFR , JAK , JNK
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK-binding negative control in the development of new therapeutics.
1 2 3 4 5 6
TargetMol